Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Pediatric Endocrinology & Metabolism (JPEM)

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/jpem-2015-0340PMID 27054595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection

  2015cited by this paper
• Diabetes mellitus in children and adolescents – a global epidemic which has become neglected

  2015cited by this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid‐induced apoptosis

  2012cited by this paper
• Anti-Inflammatory Therapy in Type 1 Diabetes

  2012cited by this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine‐induced apoptosis in vitro

  2012cited by this paper
• Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance

  2012cited by this paper
• Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

  2012cited by this paper
• Beta cell function: the role of macrophage migration inhibitory factor

  2012cited by this paper
• T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives

  2011cited by this paper
• Prevention of type 1 diabetes mellitus using a novel vaccine

  2011cited by this paper
• Macrophage migration inhibitory factor (MIF): a promising biomarker.

  2010cited by this paper
• T Cell Reactivity against Mycolyl Transferase Antigen 85 of M. tuberculosis in HIV-TB Coinfected Subjects and in AIDS Patients Suffering from Tuberculosis and Nontuberculous Mycobacterial Infections

  2010cited by this paper
• Macrophage Migration Inhibitory Factor: Critical Role in Obesity, Insulin Resistance, and Associated Comorbidities

  2010cited by this paper
• Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury

  2010cited by this paper
• Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes

  2010cited by this paper
• Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

  2009cited by this paper
• Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.

  2009cited by this paper
• Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

  2008cited by this paper
• Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.

  2007cited by this paper
• [The diabetic foot in Cameroon].

  2005cited by this paper
• Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases.

  2005cited by this paper
• Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

  2005cited by this paper
• Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

  2004cited by this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cited by this paper
• Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

  1966cited by this paper
• Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

  1966cited by this paper
• Annals of the New York Academy of Sciences Molecular Function of Macrophage Migration Inhibitory Factor and a Novel Therapy for Inflammatory Bowel Disease

  year unknowncited by this paper

• Low Serum Levels of Interleukin-6 (IL-6) and Monocyte Chemoattractant Protein-1 (MCP-1) in Immediate Postpartum Mexican Women With Gestational Diabetes

  2025cites this paper
• Type 1 Diabetes Mellitus and Host-Bacterial Interactions in the Oral Cavity

  2024cites this paper
• Clinical importance of cytokine (IL-6, IL-8, and IL-10) and vitamin D levels among patients with Type-1 diabetes

  2024cites this paper
• Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research

  2024cites this paper
• The Role of Inflammatory Mediators in the Pathogenesis of Obesity

  2024cites this paper
• Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity

  2024cites this paper
• Salivary macrophage activation-related chemokines and mitogen-activated kinase kinase (MAPKK) degrading proteolytic activity in type 1 diabetes mellitus.

  2023cites this paper
• Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability

  2023cites this paper
• Chemokines in Type 1 Diabetes Mellitus

  2022cites this paper
• The Role of Intermediate Monocytes (CD14+CD16+) in Development and Diagnosis of Recent Type 1 Diabetes in Children

  2021influential citation
• Identification of hub genes related to the progression of type 1 diabetes by computational analysis

  2021cites this paper
• MCP-1: Function, regulation, and involvement in disease

  2021cites this paper
• The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway

  2021cites this paper
• PEDF relieves kidney injury in type 2 diabetic nephropathy mice by reducing macrophage infiltration.

  2021cites this paper
• Increased spontaneous CCL2 (MCP‐1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14

  2020cites this paper
• Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk

  2020cites this paper
• Extracellular ATP Increases Glucose Metabolism in Skeletal Muscle Cells in a P2 Receptor Dependent Manner but Does Not Contribute to Palmitate-Induced Insulin Resistance

  2020influential citation
• Chromolaena odorata flavonoids attenuate experimental nephropathy: Involvement of pro-inflammatory genes downregulation

  2020cites this paper
• Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets.

  2019cites this paper
• The Role of Macrophage Migration Inhibitory Factor (MIF) in Acute Kidney Injury

  2019cites this paper
• Macrophage Migration Inhibitory Factor Levels in Gingival Crevicular Fluid, Saliva, and Serum of Chronic Periodontitis Patients

  2019cites this paper
• Inorganic arsenic induces pyroptosis and pancreatic β cells dysfunction through stimulating the IRE1α/TNF-α pathway and protective effect of taurine.

  2019cites this paper
• In vivo imaging the motility of monocyte/macrophage during inflammation in diabetic mice

  2018cites this paper
• Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?

  2018cites this paper
• Differences in Interleukin-8 Plasma Levels between Diabetic Patients and Healthy Individuals Independently on Their Periodontal Status

  2018cites this paper
• The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders

  2018cites this paper
• Association between Antioxidant Enzyme Activities and Enterovirus-Infected Type 1 Diabetic Children

  2018cites this paper
• Genistein prevention of hyperglycemia and improvement of glucose tolerance in adult non‐obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis

  2017cites this paper
• Increase in Peripheral Blood Intermediate Monocytes is Associated with the Development of Recent-Onset Type 1 Diabetes Mellitus in Children

  2017cites this paper
• ASSOCIATION OF BANK 1 GENE POLYMORPHISM WITH TYPE 1 DIABETES IN A SAMPLE OF 1

  2016cites this paper